Cargando…

A review of ropinirole prolonged release in Parkinson’s disease

Ropinirole prolonged release is a once-daily, 24-hour formulation of ropinirole, a non-ergot dopamine agonist. It is approved as monotherapy and as an adjunct to levodopa in the treatment of Parkinson’s disease (PD). Several potential advantages of ropinirole prolonged release compared to the immedi...

Descripción completa

Detalles Bibliográficos
Autores principales: Nashatizadeh, Muhammad M, Lyons, Kelly E, Pahwa, Rajesh
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2685238/
https://www.ncbi.nlm.nih.gov/pubmed/19503779